Michael Triplett, CEO of Armatus Bio, gives "the" elevator pitch for fluid-based biomarkers in this clip at the Rev1 Ventures February Founders' Story.
"Everybody (venture capital, pharma acquirers) wants a biomarker..."
www.youtube.com/watch?v=wY2Q...
#biomarkers #genetherapy #biotechnology

Greetings, Bluesky! I'm excited to try this platform. Until today, the only social media I use frequently is LinkedIn, and frankly, LI has become too "Facebook-y" for me. I'm looking for a professional platform to share and keep up with scientific insights. Have I come to the right place?